These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12386255)

  • 1. Anaemia: cardiovascular adaptations and maladaptive responses in chronic kidney disease.
    Foley RN
    Nephrol Dial Transplant; 2002; 17 Suppl 11():32-4. PubMed ID: 12386255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaemia, renal insufficiency and cardiovascular outcome.
    Hegarty J; Foley RN
    Nephrol Dial Transplant; 2001; 16 Suppl 1():102-4. PubMed ID: 11369834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of anaemia: focus on the heart and blood vessels.
    Metivier F; Marchais SJ; Guerin AP; Pannier B; London GM
    Nephrol Dial Transplant; 2000; 15 Suppl 3():14-8. PubMed ID: 11032352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing a fateful alliance: anaemia and cardiovascular outcomes.
    Eckardt KU
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi16-20. PubMed ID: 15958821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CREATE trial--building the evidence.
    Eckardt KU;
    Nephrol Dial Transplant; 2001; 16 Suppl 2():16-8. PubMed ID: 11369844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular consequences of renal anaemia and erythropoietin therapy.
    Eckardt KU
    Nephrol Dial Transplant; 1999 May; 14(5):1317-23. PubMed ID: 10344393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):383-7. PubMed ID: 12908173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should hemoglobin be normalized in uremic patients?
    Foley RN
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S58-61. PubMed ID: 12227728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaemia in chronic renal disease: lessons learned since Seville 1994.
    Parfrey P
    Nephrol Dial Transplant; 2001; 16 Suppl 7():41-5. PubMed ID: 11590256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaemia and early phase cardiovascular events on haemodialysis.
    Hayashi T; Joki N; Tanaka Y; Hase H
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():1-6. PubMed ID: 26456311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.
    Strippoli GF; Manno C; Schena FP; Craig JC
    Cochrane Database Syst Rev; 2003; (1):CD003967. PubMed ID: 12535495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin levels, cardiovascular disease, and left ventricular hypertrophy in patients with chronic kidney disease. Case study of the anemic patient.
    Butler KG
    Nephrol Nurs J; 2002 Apr; 29(2):189-92. PubMed ID: 11997954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of cardiovascular damage in early renal disease.
    Levin A
    Nephrol Dial Transplant; 2001; 16 Suppl 2():7-11. PubMed ID: 11369842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial effects of intervention in early renal disease.
    Portolés J
    Nephrol Dial Transplant; 2001; 16 Suppl 2():12-5. PubMed ID: 11369843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anaemia on cardiovascular status.
    O'Riordan E; Foley RN
    Nephrol Dial Transplant; 2000; 15 Suppl 3():19-22. PubMed ID: 11032353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study.
    Locatelli F; Aljama P; Canaud B; Covic A; De Francisco A; Macdougall IC; Wiecek A; Vanholder R;
    Nephrol Dial Transplant; 2010 Sep; 25(9):2846-50. PubMed ID: 20591813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaemia management and cardiomyopathy in renal failure.
    Donne RL; Foley RN
    Nephrol Dial Transplant; 2002; 17 Suppl 1():37-40. PubMed ID: 11812910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of cardiovascular damage in the early renal population.
    London G
    Nephrol Dial Transplant; 2001; 16 Suppl 2():3-6. PubMed ID: 11369841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualizing target haemoglobin concentrations--tailoring treatment for renal anaemia.
    Macdougall IC
    Nephrol Dial Transplant; 2001; 16 Suppl 7():9-14. PubMed ID: 11590250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-erythropoietin-based anaemia management in chronic kidney disease.
    Hörl WH
    Nephrol Dial Transplant; 2002; 17 Suppl 11():35-8. PubMed ID: 12386256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.